Covalon Technologies Ltd. (OTCMKTS:CVALF) Short Interest Update

Covalon Technologies Ltd. (OTCMKTS:CVALF) was the target of a significant drop in short interest in November. As of November 15th, there was short interest totalling 5,500 shares, a drop of 54.2% from the October 31st total of 12,000 shares. Based on an average daily volume of 51,900 shares, the short-interest ratio is currently 0.1 days.

Covalon Technologies Price Performance

OTCMKTS CVALF traded down $0.06 during trading hours on Thursday, reaching $2.48. 17,740 shares of the stock traded hands, compared to its average volume of 16,649. The stock has a 50 day simple moving average of $2.49 and a two-hundred day simple moving average of $1.94. Covalon Technologies has a 1 year low of $0.73 and a 1 year high of $3.08. The company has a market cap of $67.81 million, a price-to-earnings ratio of -82.50 and a beta of -0.34.

Covalon Technologies Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.